- Home
- CELU vs MDCX Comparison
CELU vs MDCX Comparison
Compare CELU & MDCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CELU
- MDCX
- Stock Information
- Founded
- CELU 2016
- MDCX 2008
- Country
- CELU United States
- MDCX United States
- Employees
- CELU N/A
- MDCX N/A
- Industry
- CELU Biotechnology: Pharmaceutical Preparations
- MDCX
- Sector
- CELU Health Care
- MDCX
- Exchange
- CELU Nasdaq
- MDCX Nasdaq
- Market Cap
- CELU 56.9M
- MDCX 50.8M
- IPO Year
- CELU N/A
- MDCX N/A
- Fundamental
- Price
- CELU $1.74
- MDCX $2.24
- Analyst Decision
- CELU Strong Buy
- MDCX Strong Buy
- Analyst Count
- CELU 1
- MDCX 2
- Target Price
- CELU $6.00
- MDCX $23.50
- AVG Volume (30 Days)
- CELU 153.9K
- MDCX 333.5K
- Earning Date
- CELU 12-05-2025
- MDCX 11-22-2025
- Dividend Yield
- CELU N/A
- MDCX N/A
- EPS Growth
- CELU N/A
- MDCX N/A
- EPS
- CELU N/A
- MDCX N/A
- Revenue
- CELU $44,590,000.00
- MDCX N/A
- Revenue This Year
- CELU N/A
- MDCX N/A
- Revenue Next Year
- CELU $76.00
- MDCX N/A
- P/E Ratio
- CELU N/A
- MDCX N/A
- Revenue Growth
- CELU 4.45
- MDCX N/A
- 52 Week Low
- CELU $1.00
- MDCX $1.79
- 52 Week High
- CELU $5.22
- MDCX $8.94
- Technical
- Relative Strength Index (RSI)
- CELU 34.57
- MDCX 45.12
- Support Level
- CELU $1.62
- MDCX $2.15
- Resistance Level
- CELU $1.99
- MDCX $2.60
- Average True Range (ATR)
- CELU 0.11
- MDCX 0.20
- MACD
- CELU -0.02
- MDCX -0.02
- Stochastic Oscillator
- CELU 21.15
- MDCX 16.67
About CELU Celularity Inc.
Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from the bio-banking segment.
About MDCX Medicus Pharma Ltd. Common Stock
Medicus Pharma Ltd is a clinical-stage holding company focused on investing in and accelerating novel life sciences and bio-technology companies through FDA-approved clinical trials. The Company focuses on meeting the unmet need to improve patient safety and efficacy.